Filter By Unselect All

Sub Category Unselect

Country Unselect

Companies Unselect See All

Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

Contact

Phase 1 Clinical Pharmacology Study

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Quotient has the experience and expertise to deliver studies with the highest quality service and speed to clinical data. If you need a complete service including data management, data analysis, statistics and medical writing, Quotient is your answer.

Contact

14C ADME / Mass Balance

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

Whatever Phase 1 clinical pharmacology study you require, at Quotient Sciences you can expect rapid study startup and rapid recruitment through our locations in Jacksonville, Miami and Nottingham.

Contact

Clinical PK/PD and Pharmacometrics Services

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

PAREXEL’s global team of experienced clinical pharmacokineticists and pharmacometricians offer unsurpassed expertise in Clinical PK/PD and Pharmacometrics, from pre-clinical to Phase III studies.

Contact

Phase 1 Clinical Trials

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

PAREXEL® has the global SOPs to perform Phase 1 clinical trials in harmony across multiple locations, and stands committed to the success of your journey.

Contact

Supporting Drug Development at Phase I & II

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

Contact

14C-Radiolabeled Microtracer Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

Celerion’s clinic in Lincoln, Nebraska, is the only Phase I facility in North America with proven experience to release radiolabeled drug to regulatory standards that has been formulated on site for intravenous use in humans. This is required to perform assessments of absolute bioavailability

Contact

Early Phase Clinical Trials

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

We have a speciality in early phase trials involving healthy volunteers. Early phase trials may have many factors that must be considered to achieve the research goals.

Contact

Radiolabeled ADME Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

In response to a growing interest in conducting human 14C-radiolabeled ADME studies earlier in drug development, Celerion has expanded its ADME suite in Lincoln, Nebraska.

Contact

Phase lla

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

PAREXEL® has developed an integrated and adaptive approach that supports Phase IIa outcomes.

Contact

Global CRO- Phase I & ll Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

With over 40 years of experience, more than 600 beds in North America and Europe, Celerion offers the largest global Phase I and II clinical operations networks in the industry.

PharmaCompass >>